BMY vs DRIO · P/E 17, rev $24.46B vs rev $10.8M
Bristol-Myers Squibb Company (BMY) versus DarioHealth Corp (DRIO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
DarioHealth Corp (DRIO) is a health information services company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DRIO revenue for 2026-06-30 was $10.8M. Net income was -$16.2M. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. DRIO currently screens at market cap $52.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DRIO currently screens at market cap $52.1M.
Not investment advice. Open the BMY and DRIO stock pages for the full models.
Not investment advice.